Figure 2.
Figure 2. OS was assessed in BALB/c mice that underwent transplant with bone marrow transduced with FLT3-ITD and treated with midostaurin 100 mg/kg per day or placebo. Half of the mice were treated from days 30 to 88; the remaining mice were treated from days 25 to 68. Adapted from Weisberg et al46 with permission.

OS was assessed in BALB/c mice that underwent transplant with bone marrow transduced with FLT3-ITD and treated with midostaurin 100 mg/kg per day or placebo. Half of the mice were treated from days 30 to 88; the remaining mice were treated from days 25 to 68. Adapted from Weisberg et al46  with permission.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal